Mircette is a combination of female hormones used to prevent ovulation and pregnancy. Active substance: Ethinylestradiol + Drospirenone.
Contraceptives (estrogen + progestogen)
Estrogens, progestins; antagonists, and their homologues in combination]
Ingredients of Mircette: film-coated tablets.
ethinyl estradiol 30 mcg
Drospirenone 3 mg
Excipients of Mircette: lactose monohydrate – 48.17 mg; corn starch – 14.4 mg; pregelatinized corn starch – 9.6 mg; povidone K25 – 4 mg; magnesium stearate – 800 mg; hypromellose (hydroxypropyl) – 1.0112 mg; macrogol 6000 – 202.4 g; talc (hydrous magnesium silicate) – 202.4 g; titanium dioxide (E171) – 556.5 g; iron (II) oxide (E172) – 27.5 g
Mircette is a birth control pill used for contraception to prevent pregnancy. Mircette may also be used for purposes not listed in this medication guide.
Indications for use Mircette
Contraception (prevention of unwanted pregnancy).
The drug should not be applied if any of the conditions / diseases listed below:
thrombosis (venous and arterial) and thromboembolism present or in history (including deep vein thrombosis, pulmonary embolism, myocardial infarction, stroke), cerebrovascular disorders;
state prior thrombosis (including transient ischemic attack, angina pectoris) now or in history;
migraine with focal neurological symptoms now or in history;
diabetes with vascular complications;
expressed or multiple venous or arterial thrombosis risk factors, including complicated lesion valvular atrial fibrillation, cerebrovascular disease, or coronary artery; uncontrolled hypertension, major surgery with prolonged immobilization, smoking at the age of 35 years;
pancreatitis with severe hypertriglyceridemia now or in history;
hepatic failure and severe liver disease (liver function tests before normalization);
liver tumors (benign or malignant), or at the moment in history;
severe and / or acute renal failure;
hormone-dependent cancers identified (including genital or mammary glands) or are suspected;
vaginal bleeding of unknown origin;
pregnancy or suspicion of it;
hypersensitivity to any component of drug.
If any of these conditions develop for the first time while taking the tablets, the drug should be immediately repealed.
Conditional contraindications of Mircette
the presence of the following diseases / conditions and risk factors:
Thrombosis risk factors for thromboembolism: smoking, obesity, dislipoproteinemia, hypertension, migraine, valvular disease, prolonged immobilization, major surgery, major trauma, genetic predisposition to thrombosis (thrombosis, myocardial infarction or cerebrovascular accident at a young age who of-or the next of kin);
Other diseases in which may occur peripheral circulatory disorders (diabetes mellitus, systemic lupus erythematosus, hemolytic uremic syndrome, Crohn’s disease and ulcerative colitis, sickle-cell anemia), phlebitis of superficial veins;
the disease first appeared during pregnancy, or on the background of the previous use of sex hormones (such as jaundice and / or pruritus related to cholestasis, cholelithiasis, otosclerosis with hearing impairment, porphyria, herpes gestationis, Sydenham’s chorea);
Side effects of Mircette
Psychiatric disorders: Mood swings, depression, depressed mood, decrease or loss of libido
Nervous System: Migraine
Violations of the vessels: venous or arterial thromboembolism *
Skin and subcutaneous tissue disorders: erythema multiforme
Reproductive system and breasts: breast pain, irregular uterine bleeding, bleeding from the genital tract of unspecified origin